HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

KIOM-79 prevents S100b-induced TGF-beta1 and fibronectin expression in mouse mesangial cells.

AbstractAIM OF THE STUDY:
In this study, we investigated whether KIOM-79 inhibits transforming growth factor-beta 1 (TGF-beta1) and fibronectin expression in mouse mesangial cells cultured under S100b, a specific ligand of the receptor for advanced glycation end products (RAGE).
MATERIALS AND METHODS:
Cell counting kit (CCK-8) assay was employed to evaluate the viability of KIOM-79-treated mesangial cells. The effect of KIOM-79 on S100b-induced TGF-beta1 and fibronectin expression was investigated using RT-PCR, ELISA, and Western blot on mesangial cells.
RESULTS:
KIOM-79 (up to 50 microg/ml) appeared to have no effect on cell viability. S100b induced an increase in the expression TGF-beta1 and fibronectin. Expression of TGF-beta1 and fibronectin was inhibited significantly by KIOM-79 treatment in mesangial cells. KIOM-79 also inhibited the expression of NF-kB and inactivated p38 mitogen-activated protein kinase (MAPK) and extracellular signal-regulated kinase (ERK) 1/2 in mesangial cells. KIOM-79 pretreatment inhibited increased malondialdehyde (a product of lipid peroxidation and a marker for oxidative stress) levels in S100b-induced mesangial cells.
CONCLUSIONS:
These data demonstrate that KIOM-79 inhibits expression of TGF-beta1 and fibronectin through inactivation of MAPK/ERK1/2 signaling, reduction in malondiadehyde levels, and inhibition of NF-kB in mesangial cells cultured under diabetic conditions. KIOM-79 could be beneficial for preventing of the development of diabetic complications such as nephropathy.
AuthorsDong Ho Jung, Young Sook Kim, Jin Sook Kim
JournalJournal of ethnopharmacology (J Ethnopharmacol) Vol. 125 Issue 3 Pg. 374-9 (Sep 25 2009) ISSN: 1872-7573 [Electronic] Ireland
PMID19666101 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Fibronectins
  • KIOM 79
  • NF-kappa B
  • Plant Extracts
  • RNA, Messenger
  • S100 Proteins
  • Transforming Growth Factor beta1
  • Malondialdehyde
  • Mitogen-Activated Protein Kinase 1
  • Mitogen-Activated Protein Kinase 3
  • p38 Mitogen-Activated Protein Kinases
Topics
  • Animals
  • Cell Line
  • Cell Survival (drug effects)
  • Dose-Response Relationship, Drug
  • Fibronectins (genetics, metabolism)
  • Malondialdehyde (antagonists & inhibitors)
  • Mesangial Cells (metabolism)
  • Mice
  • Mitogen-Activated Protein Kinase 1 (antagonists & inhibitors)
  • Mitogen-Activated Protein Kinase 3 (antagonists & inhibitors)
  • NF-kappa B (antagonists & inhibitors)
  • Phosphorylation (drug effects)
  • Plant Extracts (pharmacology)
  • RNA, Messenger (metabolism)
  • S100 Proteins (pharmacology)
  • Time Factors
  • Transforming Growth Factor beta1 (metabolism)
  • p38 Mitogen-Activated Protein Kinases (antagonists & inhibitors)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: